Literature DB >> 12440610

Significant improvement of heart function by cotransplantation of human mesenchymal stem cells and fetal cardiomyocytes in postinfarcted pigs.

Jiang-Yong Min1, Matthew F Sullivan, Yinke Yang, Jian-Ping Zhang, Kimber L Converso, James P Morgan, Yong-Fu Xiao.   

Abstract

BACKGROUND: Viable cardiomyocytes after myocardial infarction (MI) are unable to repair the necrotic myocardium due to their limited capability of regeneration. The present study investigated whether intramyocardial transplantation of human mesenchymal stem cells (hMSCs) or cotransplantation of hMSCs plus human fetal cardiomyocytes (hFCs; 1:1) reconstituted impaired myocardium and improved cardiac function in MI pigs. METHODS AND
RESULTS: Cultured hMSCs were transfected with green fluorescent protein (GFP). Six weeks after MI induction and cell transplantation, cardiac function was significantly improved in MI pigs transplanted with hMSCs alone. However, the improvement was even markedly greater in MI pigs cotransplanted with hMSCs plus hFCs. Histological examination demonstrated that transplantation of hMSCs alone or hMSCs plus hFCs formed GFP-positive engrafts in infarcted myocardium. In addition, immunostaining for cardiac alpha-myosin heavy chain and troponin I showed positive stains in infarcted regions transplanted with hMSCs alone or hMSCs plus hFCs.
CONCLUSIONS: Our data demonstrate that transplantation of hMSCs alone improved cardiac function in MI pigs with a markedly greater improvement from cotransplantation of hMSCs plus hFCs. This improvement might result from myocardial regeneration and angiogenesis in injured hearts by engrafted cells.

Entities:  

Mesh:

Year:  2002        PMID: 12440610     DOI: 10.1016/s0003-4975(02)03952-8

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  40 in total

1.  Human mesenchymal stem cells make cardiac connexins and form functional gap junctions.

Authors:  Virginijus Valiunas; Sergey Doronin; Laima Valiuniene; Irina Potapova; Joan Zuckerman; Benjamin Walcott; Richard B Robinson; Michael R Rosen; Peter R Brink; Ira S Cohen
Journal:  J Physiol       Date:  2004-02-06       Impact factor: 5.182

Review 2.  Stem celltherapy for ischemic heart failure.

Authors:  Doreen Rosenstrauch; Gregor Poglajen; Nina Zidar; Igor D Gregoric
Journal:  Tex Heart Inst J       Date:  2005

Review 3.  Stem cell treatment of the heart: a review of its current status on the brink of clinical experimentation.

Authors:  Paolo Angelini; Roger R Markwald
Journal:  Tex Heart Inst J       Date:  2005

4.  The mechanical coupling of adult marrow stromal stem cells during cardiac regeneration assessed in a 2-D co-culture model.

Authors:  Mani T Valarmathi; John W Fuseler; Richard L Goodwin; Jeffrey M Davis; Jay D Potts
Journal:  Biomaterials       Date:  2011-02-01       Impact factor: 12.479

5.  Malignant tumor formation after transplantation of short-term cultured bone marrow mesenchymal stem cells in experimental myocardial infarction and diabetic neuropathy.

Authors:  Jin-Ok Jeong; Ji Woong Han; Jin-Man Kim; Hyun-Jai Cho; Changwon Park; Namho Lee; Dong-Wook Kim; Young-Sup Yoon
Journal:  Circ Res       Date:  2011-04-14       Impact factor: 17.367

Review 6.  Cardiac applications for human pluripotent stem cells.

Authors:  Yuji Shiba; Kip D Hauch; Michael A Laflamme
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

7.  Direct intracardiac injection of umbilical cord-derived stromal cells and umbilical cord blood-derived endothelial cells for the treatment of ischemic cardiomyopathy.

Authors:  Paula H Suss; Luiz Guilherme A Capriglione; Fabiane Barchiki; Lye Miyague; Danielle Jackowski; Letícia Fracaro; Andressa V Schittini; Alexandra C Senegaglia; Carmen L K Rebelatto; Márcia Olandoski; Alejandro Correa; Paulo R S Brofman
Journal:  Exp Biol Med (Maywood)       Date:  2015-01-08

8.  Diabetes reduces mesenchymal stem cells in fracture healing through a TNFα-mediated mechanism.

Authors:  Kang I Ko; Leila S Coimbra; Chen Tian; Jazia Alblowi; Rayyan A Kayal; Thomas A Einhorn; Louis C Gerstenfeld; Robert J Pignolo; Dana T Graves
Journal:  Diabetologia       Date:  2015-01-07       Impact factor: 10.122

Review 9.  Cardiac progenitor cells and bone marrow-derived very small embryonic-like stem cells for cardiac repair after myocardial infarction.

Authors:  Xian-Liang Tang; D Gregg Rokosh; Yiru Guo; Roberto Bolli
Journal:  Circ J       Date:  2010-01-18       Impact factor: 2.993

Review 10.  Lost in translation: what is limiting cardiomyoplasty and can tissue engineering help?

Authors:  David Simpson; Samuel C Dudley
Journal:  Curr Stem Cell Res Ther       Date:  2009-09       Impact factor: 3.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.